Showing results (321-330 of 391) with videos related to

Sort By:
Pageof 40
Journal of Translational Medicine|April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinSachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2023
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?Roni Nitecki, Pedro T Ramirez, Pavel Dundr, et al.
Obstetrics and Gynecology|February 19, 2026
Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysisYoshikazu Nagase, Shinya Matsuzaki, Hiroshi Yoshida, et al.
JAMA Network Open|November 21, 2024
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: A LANCE Randomized Clinical TrialJ Alejandro Rauh-Hain, Alexander Melamed, René Pareja, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2025
Impact of an enhanced recovery after surgery program on outcomes in elderly patients undergoing open gynecologic surgeryMaria D Iniesta, Mark F Munsell, Andres Zorrilla-Vaca, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2014
Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidenceLauren S Prescott, Lisa M Kidin, Rebecca L Downs, et al.
Obstetrics and Gynecology|May 6, 2021
Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian CancerRoni Nitecki, Mark A Clapp, Shuangshuang Fu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 30, 2020
Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancerCourtney D Bailey, Rebecca Previs, Bryan M Fellman, et al.
Pageof 40